Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
AI is offering hope for making earlier diagnoses in pancreas cancer, historically diagnosed later in the disease when treatment outcomes may not be as good. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: …
AI may help diagnose early pancreas cancer, Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:00 — 1.4MB)
Subscribe: RSS
Cells that can be found in a routine Pap smear may hold the key to detecting and diagnosing ovarian cancer much earlier than it is usually found, a new study reports. Johns Hopkins Kimmel Cancer Center director William Nelson says …
Will a new test make finding ovarian cancer earlier easier? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:00 — 1.4MB)
Subscribe: RSS
CAR-T cells, which are immune cells removed from the body, genetically modified in a laboratory and then reinfused back into a recipient, have achieved notable successes in treating some cancers. Now there have also been reports of people being treated …
Might CAR-T cells cause cancer rather than cure it? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
CAR-T cells, used to treat cancer in some people, are now being investigated by the US Food and Drug Administration for possibly causing additional cancers. Kimmel Cancer Center director William Nelson at Johns Hopkins explains why there’s a concern. Nelson: …
Why are CAR-T cell therapies being investigated by the FDA? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:07 — 1.5MB)
Subscribe: RSS
If you’re a current or former smoker, screening guidelines for lung cancer keep changing, with the newest guidelines from the American Cancer Society expanding the pool of people who would be eligible for CT screening. Kimmel Cancer Center director William …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Bladder cancer has historically been difficult to treat, but now a new strategy involving hooking a custom made antibody to a drug seems to be extending survival. Known as antibody/drug conjugates, William Nelson, director of the Kimmel Cancer Center at …
